HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) - CLASS II - ANVISA Registration 80537410053

Access comprehensive regulatory information for HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) - CLASS II in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80537410053 and manufactured by GUANGZHOU WONDFO BIOTECH CO., LTD.. The registration is held by CELER BIOTECNOLOGIA S/A with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, RESPONSE BIOMEDICAL CORP., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80537410053
Registration Details
ANVISA Registration Number: 80537410053
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80537410053

25351749176201922

04846613000103

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Jul 06, 2020

VIGENTE

09/18/2025 19:00:01